Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vinyl-containing pyrimidine formamide compound, composition and application of compound and composition

A compound and formamide technology, applied in the field of medicinal chemistry, can solve problems such as high homology, low selectivity of JAK inhibitors, and small structural differences

Active Publication Date: 2020-01-31
BEIJING SCITECH MQ PHARMA LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The ATP binding sites of several subtypes of JAK kinases have high homology and small structural differences, which is an important reason for the low selectivity of JAK inhibitors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vinyl-containing pyrimidine formamide compound, composition and application of compound and composition
  • Vinyl-containing pyrimidine formamide compound, composition and application of compound and composition
  • Vinyl-containing pyrimidine formamide compound, composition and application of compound and composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Example 1 Preparation of 4-(butyl-3-en-1-ylamino)-2-((1-(tert-butyl)-1H-pyrazol-4-yl)amino]pyrimidine-5-carboxamide :

[0071]

[0072] Step 1): Preparation of 2-chloro-4-(butyl-3-en-1-ylamino)pyrimidine-5-carboxamide:

[0073] Dissolve 2,4-dichloropyrimidine-5-carboxamide (400mg, 2.08mmol) and triethylamine (633mg, 6.25mmol) in tetrahydrofuran (10mL), add butyl-3-en-1-amine hydrochloride Salt (225mg, 2.1mmol), react at 25°C for 3 hours. Add saturated brine (200 mL), stir for 15 minutes, filter, and wash the filter cake with petroleum ether to obtain 380 mg of white solid, MS: 227 [M+H] + .

[0074]

[0075] Step 2): 4-(Butyl-3-en-1-ylamino)-2-((1-(tert-butyl)-1H-pyrazol-4-yl)amino]pyrimidine-5-carboxamide preparation:

[0076] Dissolve 2-chloro-4-(butyl-3-en-1-ylamino)pyrimidine-5-carboxamide (70 mg, 0.29 mmol) in sec-butanol (3 mL), add 1-tert-butyl-1H - Pyrazol-4-amine (49mg, 0.35mmol) and trifluoroacetic acid (0.1mL) were reacted at 100°C with locking tu...

Embodiment 2

[0077] Example 2 Preparation of 2-((1-tert-butyl-1H-pyrazol-4-yl)amino)-4-((2-methallyl)amino)pyrimidine-5-carboxamide:

[0078] The operation is the same as in Example 1, but butyl-3-en-1-amine hydrochloride in step 1) is replaced with 2-methylpropyl-2-en-1-amine to obtain a white solid, 1 H NMR (400MHz, DMSO-d 6 )δ10.36(s,1H),10.12(s,1H),8.55(s,1H),8.29–8.09(m,1H),7.98(s,1H),7.70–7.49(m,2H),4.90 –4.80(m, 2H), 4.10(d, J=5.7Hz, 2H), 1.76(s, 3H), 1.51(s, 9H). Chemical formula: C 16h 23 N 7 O, MS: 330 (M+H) + .

Embodiment 3

[0079] Example 3 2-((1-(tert-butyl)-1H-pyrazol-4-yl)amino)-4-((3-methylbutyl-2-en-1-yl)amino)pyrimidine- Preparation of 5-formamide:

[0080]

[0081] The operation is the same as in Example 1, and butyl-3-en-1-amine hydrochloride in step 1) is replaced with 3-methylbutyl-2-en-1-amine to obtain a white solid, 1 H NMR (400MHz, DMSO-d 6 )δ10.48(s,1H),9.94(s,1H),8.51(s,1H),8.36–8.10(m,1H),8.06(s,1H),7.81–7.40(m,2H),5.41 –5.22(m,1H),4.24–3.92(m,2H),1.71(s,3H),1.67(s,3H),1.50(s,9H).Chemical formula: C 17 h 25 N 7 O, MS: 344 (M+H) + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new compound serving as a JAK inhibitor, a composition and an application of the new compound and the composition. Specifically, the invention provides the compound (represented by a formula (1)) with strong JAK inhibitory activity or an isomer, a solvate, a hydrate, a pharmaceutically acceptable salt and a prodrug thereof, and the pharmaceutical composition containing the compound. The invention further discloses the application of the compound or the pharmaceutical composition in preparation of a medicine. The medicine is used for treating autoimmune diseases or cancers.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a class of alkenyl-containing pyrimidine carboxamide compounds, their isomers, hydrates, solvates, pharmaceutically acceptable salts or prodrugs, pharmaceutical compositions thereof, and their Application in the preparation of drugs for treating autoimmune diseases and cancers related to tyrosine kinases JAK1, JAK2, JAK3 and TYK2. Background technique [0002] JAK kinase (Janus kinase) and its downstream effectors, signal transducers and transcriptional activators form an important cytokine signaling pathway - JAK-STAT pathway. Studies have found that the JAK-STAT pathway can be activated by a variety of cytokines, growth factors and receptors, and participate in cell proliferation, differentiation, apoptosis, angiogenesis and immune regulation. JAK kinase is a key kinase in the JAK-STAT signaling pathway. More than 20 years after the enzyme was discovered, the fir...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D403/12C07D405/14A61K31/506A61P35/00A61P35/02A61P27/02A61P17/06A61P17/00A61P17/14A61P19/02A61P1/00A61P9/10A61P37/02A61P1/16
CPCA61P1/00A61P1/16A61P9/10A61P17/00A61P17/06A61P17/14A61P19/02A61P27/02A61P35/00A61P35/02A61P37/02C07D403/12C07D405/14
Inventor 张强刘彦生李兰涛李兴福胡晨明
Owner BEIJING SCITECH MQ PHARMA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com